Grantham, Mayo, Van Otterloo & Co (GMO)
BNR

Grantham, Mayo, Van Otterloo & Co (GMO)’s Burning Rock Biotech BNR Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,080
Closed -$1.34M – 698
2021
Q4 		$1.34M Buy
+14,080
New +$1.93M 0.01% 514

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s BNR Position: Q1 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Burning Rock Biotech (BNR) in Q1 2022, closing a stake of 14,080 shares — an estimated $1.34M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BNR in Q4 2021 and held it in 1 quarter. The position peaked at $1.34M in Q4 2021. 46 funds tracked by Wall St. Rank hold BNR as of Q1 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Burning Rock Biotech position as of Q1 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 14,080 Burning Rock Biotech shares in Q1 2022, an estimated $1.34M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Burning Rock Biotech in Q4 2021 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Burning Rock Biotech position peaked at $1.34M in Q4 2021.
  • 46 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2022, filed 13 May 2022.